We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITRI:NASDAQItron, Inc. analysis

Data as of Sep 17, 2026 - not real-time

Latest price
$91.58
Risk: medium
6/10Medium risk

Summary

Itron, Inc. trades at $91.58, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has lost 13.3%. Relative strength is 37.3 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at $90.94 and resistance at $100.77.
Multiples put this in undervalued territory: 15.3 times earnings against the sector's 33.3. The average analyst target implies 41.5% above today's level. Revenue is contracting at 7.2% on a 11.9% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 22.6%, a beta of 1.46 and a maximum drawdown of 43.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top market events

  • Signia Capital Management, a boutique money management firm focusing on Small-Micro Cap and Small Cap Value investing,...
  • Looking back on inspection instruments stocks’ Q2 earnings, we examine this quarter’s best and worst performers,...
  • Looking back on inspection instruments stocks’ Q2 earnings, we examine this quarter’s best and worst performers,...

Market outlook

Short term

< 1 year

Positive

Model confidence5/105 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading below the 200-day average of 92.22
  • MACD momentum is negative

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 15.3 versus sector average of 33.3
  • Trading below the 200-day average of 92.22

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 15.3 versus sector average of 33.3
  • Analyst targets imply +41.5% versus the current price
  • Revenue contracting at -7.2%

Key metrics

Financial health

Revenue Growth-7.20%
Profit Margin11.89%
P/E Ratio15.3
ROE16.89%
ROA4.99%
Debt/Equity97.75
P/B Ratio2.5
Op. Cash Flow$410.7M
Free Cash Flow$295.3M
Industry P/E33.3

Technical analysis

TrendBullish
RSI37.3
Support$90.94
Resistance$100.77
MA 20$95.93
MA 50$95.04
MA 200$92.22
MACDBearish
VolumeIncreasing
Fear & Greed Index93.46

Valuation

Fair Value$63.23
Target Price$129.60
Upside/Downside41.52%
GradeUndervalued
TypeBlend

Risk assessment

Beta1.46
Volatility22.56%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.